Feedback / Questions
RAG-17 - Ractigen Therap
https://www.prnewswire.com/news-releases/ractigen-therapeutics-announces-first-patient-dosed-in-phase-ii-clinical-trial-of-rag-17-for-sod1-als-302659587.html
Jan 13, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next